Iskra Pusic, MD, MSCI, Washington University School of Medicine, St. Louis, MO, shares some of the highlights in graft-versus-host disease (GvHD) that were presented at this year's Tandem Meetings, drawing focus on the use of biomarkers to guide treatment. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть